KorrekturOpen Access · CC BY-NC 4.0
Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies
The Oncologist · 05.11.2026 · 31 (12)
DOI: 10.1093/oncolo/oyag418 ↗Kurz gefasst
Korrektur in der Zeitschrift The Oncologist, online erschienen am 05.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies. The Oncologist, 31(12). https://doi.org/10.1093/oncolo/oyag418
Vancouver
Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies. The Oncologist. 2026;31(12). doi:10.1093/oncolo/oyag418
BibTeX
@article{euvimed2026,
title = {Correction to: Characterization of the safety profile of trastuzumab deruxtecan by dose: a pooled analysis across DESTINY studies},
journal = {The Oncologist},
year = {2026},
volume = {31},
number = {12},
doi = {10.1093/oncolo/oyag418}
}
EUVIMED